Prevalence and Significance of Pancreatic Iron in Transfusion‐Dependent Sickle Cell Disease
Pediatric Blood & Cancer · 2025
DOI: 10.1002/pbc.31780 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Blood & Cancer, 2025. Verfasst von Akhila Vadivelan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Division of Pediatric Hematology/Oncology, UCLA Mattel Children's Hospital, Los Angeles, California, USA. Hauptthemen laut MEDLINE: Anemia, Sickle Cell, Iron Overload, beta-Thalassemia, Pancreas. Die Arbeit nennt 8 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NCATS NIH HHS, Philips Medical Systems.
Abstract (Originalsprache)
Background
Chronically transfused patients with sickle cell disease (SCD) and beta thalassemia major (TM) develop iron overload.
Objective
Determine the impact of iron overload on glucose regulation in SCD.
Methods
Prospective study of 28 patients with SCD and 38 patients with TM who underwent liver and pancreas R 2 * measurements and oral glucose tolerance tests.
Results
Impaired fasting glucose (2 vs. 9, p = 0.27) and impaired glucose tolerance (1 vs. 11, p = 0.019) were less common in patients with SCD compared with patients with TM. No SCD patient had diabetes.
Conclusion
Iron‐mediated glucose dysregulation is present but less common in SCD patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Division of Pediatric Hematology/Oncology, UCLA Mattel Children's Hospital, Los Angeles, California, USA.
- Department of Clinical Radiology, USC Keck School of Medicine, Children's Hospital of Los Angeles, Los Angeles, California, USA.
- Department of Pediatrics, Cancer and Blood Disease Institute, Section of Hematology, USC Keck School of Medicine, Children's Hospital of Los Angeles, Los Angeles, California, USA.
- Department of Pediatrics, Division of Cardiology, USC Keck School of Medicine, Children's Hospital of Los Angeles, Los Angeles, California, USA.
ORCID-Profile: Akhila Vadivelan, John C Wood
Förderung
- NIDDK NIH HHS
- NCATS NIH HHS
- Philips Medical Systems
- Saban Research Institute
Zitieren
APA
Vadivelan, A., Doyle, E., Carson, S., Denton, C., Veluswamy, S., Hofstra, T., Coates, T., & Wood, J. C. (2025). Prevalence and Significance of Pancreatic Iron in Transfusion‐Dependent Sickle Cell Disease. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.31780
Vancouver
Vadivelan A, Doyle E, Carson S, Denton C, Veluswamy S, Hofstra T, et al. Prevalence and Significance of Pancreatic Iron in Transfusion‐Dependent Sickle Cell Disease. Pediatric Blood & Cancer. 2025. doi:10.1002/pbc.31780
BibTeX
@article{Vadivelan2025,
author = {Vadivelan, Akhila and Doyle, Eamon and Carson, Susan and Denton, Christopher and Veluswamy, Saranya and Hofstra, Thomas and Coates, Thomas and Wood, John C},
title = {Prevalence and Significance of Pancreatic Iron in Transfusion‐Dependent Sickle Cell Disease},
journal = {Pediatric Blood & Cancer},
year = {2025},
doi = {10.1002/pbc.31780}
}
EUVIMED